Med Page Today
MARCH 4, 2024
(MedPage Today) -- The FDA said that it will not object to the use of a qualified health claim that eating yogurt is associated with a reduced risk of type 2 diabetes, the agency announced Friday. After a review of the evidence -- albeit limited.
Dr. Smith's ECG Blog
MARCH 4, 2024
I have often written about how an ECG interpreted as "normal" by a conventional algorithm may well be manifesting OMI, or even long QT or hyperkalemia. I have collected 51 OMI cases that were diagnosed as completely normal by the conventional automated computer algorithm. Shifa Karim and Gabe Keller helped with a project to assess all these ECGs with the Queen of Hearts.
HCPLive
MARCH 4, 2024
The overall effect of psychological interventions on patients with fibromyalgia was -0.31 for depressive symptoms and -0.15 for anxiety symptoms, which were deemed statistically significant.
Cardiology Update
MARCH 4, 2024
The optimal surveillance strategy after percutaneous coronary intervention (PCI) for high-risk patients with multivessel or left main coronary artery disease (CAD) remains uncertain. In the the POST-PCI (Pragmatic Trial Comparing Symptom-Oriented Versus Routine Stress Testing in High-Risk Patients Undergoing Percutaneous Coronary Intervention; NCT03217877 ) trial, recently published in JACC, investigators aimed to determine prognostic role of routine functional testing in patients with multivess
Becker's Hospital Review - Cardiology
MARCH 4, 2024
"Discover the incredible story of Bert Janssen, the Dutch man who has lived with a donor heart for 39 years and 252 days, officially confirmed as the world's lo
Med Page Today
MARCH 4, 2024
(MedPage Today) -- Note that some links may require registration or subscription. Trader Joe's is recalling more than 61,000 pounds of chicken soup dumplings for possibly containing hard plastic. (AP) CVS and Walgreens plan to start dispensing.
HCPLive
MARCH 4, 2024
This is the first instance in which a patient without a response to sequential bronchial thermoplasty, dupilumab, benralizumab, and mepolizumab ended up with a strong clinical response to tezepelumab.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
HCPLive
MARCH 4, 2024
Results identified mesangial IgM deposition as an independent risk factor for ESKD in patients with IgAN, particularly in advanced disease stages.
Science Daily - Stroke
MARCH 4, 2024
More than 80% of stroke survivors experience walking difficulty, significantly impacting their daily lives, independence, and overall quality of life. Now, new research pushes forward the bounds of stroke recovery with a unique robotic hip exoskeleton, designed as a training tool to improve walking function. This invites the possibility of new therapies that are more accessible and easier to translate from practice to daily life compared to current rehabilitation methods.
HCPLive
MARCH 4, 2024
In this episode, hosts are joined by SURMOPUNT-2 principal investigator Timothy Garvey, MD, to discuss the approval of the tirzepatide for chronic weight management, data from the SURMOUNT-2, -3, and 4 programs, the future of incretin therapies, and more.
Becker's Hospital Review - Cardiology
MARCH 4, 2024
Research labs are not necessarily known for the leadership opportunities they create. But for Bernard Kühn, MD, the lab helped lay the groundwork of leadership and administrative work that helped him land his current position.
Frontiers in Cardiovascular Medicine
MARCH 4, 2024
Totally endoscopic robotic mitral valve repair is the least invasive surgical therapy for mitral valve disease. Robotic mitral valve surgery demonstrates faster recovery with shorter hospital stays, less morbidity, and equivalent mortality and mid-term durability compared to sternotomy. In this review, we will explore the advantages and disadvantages of robotic mitral valve surgery and consider important technical details of both operative set-up and mitral valve repair techniques.
HCPLive
MARCH 4, 2024
The latest analysis of the Mass General Brigham Lp(a) Registry highlights Lp(a)'s independent association with cardiovascular events, with these associations apparent in patients regardless of baseline cardiovascular history.
Circulation: Cardiovascular Interventions
MARCH 4, 2024
Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Transcatheter edge-to-edge mitral valve (MV) repair (TEER) is an effective treatment for patients with primary mitral regurgitation at prohibitive risk for surgical MV repair (MVr). High-volume MVr centers and high-volume TEER centers have better outcomes than low-volume centers, respectively.
Stroke Journal
MARCH 4, 2024
Stroke, Ahead of Print. The impacts of accumulating atmospheric greenhouse gases on the earth’s climate are now well established. As a result, there have been increases in ambient temperatures and resultant higher frequency and duration of temperature extremes and other extreme weather events, which have been linked to a wide range of adverse health outcomes.
Frontiers in Cardiovascular Medicine
MARCH 4, 2024
Objective The link between sleep quality and hypertension risk is well-established. However, research on the specific dose-relationship between objective sleep characteristics and hypertension incidence remains limited. This study aims to explore the dose-relationship association between objective sleep characteristics and hypertension incidence. Methods A community-based prospective cohort study design was employed using data from the Sleep Heart Health Study (SHHS).
American College of Cardiology
MARCH 4, 2024
Hemoglobin (Hb) threshold for red cell transfusion in myocardial infarction (MI) with anemia has been a matter of debate. Previous randomized trials have not consistently shown a benefit of liberal transfusion strategy.
Frontiers in Cardiovascular Medicine
MARCH 4, 2024
Kounis Syndrome (KS), a seldom-seen adverse reaction to iodine contrast agents, has an incidence that remains unclear. At present, there are no unified guidelines for managing KS either nationally or internationally. Ioversol, a new triiodinated hypotonic nonionic contrast agent, is commonly used in cardiovascular Computed Tomography (CT) and vascular imaging for diagnostic purposes.
American College of Cardiology
MARCH 4, 2024
In these panel discussions, host Andrea Price MS, AACC brings together Kim Guibone, DNP, ACNP-BC, FACC, Susan Schnell, ACNP and Bailey Estes MSN, AGNP-C, to explore best practices related to structural heart disease.
Frontiers in Cardiovascular Medicine
MARCH 4, 2024
Introduction SARS-CoV-2 infection affects the cardiopulmonary system in the acute as well as long-term phase. The aim of the present study was to comprehensively assess symptoms and possible long-term impairments 6 and 18 months after hospitalization for severe COVID-19 infection. Methods This prospective registry included patients with PCR-confirmed COVID-19 infection requiring hospitalization.
ADN Center of Excellence
MARCH 4, 2024
Staying up to date on the newest breakthroughs in medicine is not only advantageous, but also necessary. While online certification courses are convenient, they can lack the depth of knowledge and practical experience that hands-on training offers. In this post, we'll look at why hands-on medical training is so important and should be a part of every doctor's career growth.
Frontiers in Cardiovascular Medicine
MARCH 4, 2024
Objective To investigate the effects of different rehabilitation modalities on cardiopulmonary function in patients with acute coronary syndrome after revascularization. Methods Two randomized controlled trials were conducted. All patients were stable for more than 48 h and less than 1 week after revascularization for acute coronary syndrome and were randomly assigned to Group A (home-based rehabilitation group) or Group B (center guided home-based rehabilitation group).
HCPLive
MARCH 4, 2024
This analysis explored views on safety, general levels of trust, and preferences on examination methods, with the goal being a greater awareness of opinion on AI incorporation.
Frontiers in Cardiovascular Medicine
MARCH 4, 2024
Atherosclerotic coronary artery disease (CAD) is the causal pathological process driving most major adverse cardiovascular events (MACE) worldwide. The complex development of atherosclerosis manifests as intimal plaque which occurs in the presence or absence of traditional risk factors. There are numerous effective medications for modifying CAD but new pharmacologic therapies require increasingly large and expensive cardiovascular outcome trials to assess their potential impact on MACE and to ob
American College of Cardiology
MARCH 4, 2024
The goal of the TALOS-AMI trial was to assess whether de-escalating dual antiplatelet therapy (DAPT) with clopidogrel rather than ticagrelor 1 month after percutaneous coronary intervention (PCI) for an acute myocardial infarction (AMI) would be a noninferior strategy.
Becker's Hospital Review - Cardiology
MARCH 4, 2024
New York City-based Columbia University Vagelos College of Physicians and Surgeons launched its $50 million pediatric cardiovascular innovation center.
HCPLive
MARCH 4, 2024
Clobetasol propionate ophthalmic suspension 0.05% for post-ocular surgery pain marks the first new steroid in the ophthalmic market in over 15 years.
Journal of Cardiothoracic Surgery
MARCH 4, 2024
To observe the occurrence of related complications after self-expandable metallic (SEM) airway stents implantation with different diameters at different time points, and to provide theoretical basis for the op.
Physiologically Speaking
MARCH 4, 2024
Greetings! Today, I’m (re)releasing a conversation I had with Dr. Brad Stanfield. This was initially an episode of my podcast, but now this is the only place you’ll find it. We talk about what “longevity” means, research on diet, supplements, and exercise for longevity, and controversies in the longevity field. See below for Dr.
HCPLive
MARCH 4, 2024
Our February 2024 month in review highlights some of our top hepatology content from the past few weeks, including pipeline updates, phase 2/3 trial data, and new research in liver diseases.
American College of Cardiology
MARCH 4, 2024
The following are key points to remember from a position statement on below-the-knee (BTK) endovascular revascularization.
HCPLive
MARCH 4, 2024
Our February 2024 cardiology month in review, recaps FDA news, top data from International Stroke Conference and major journals, and perspectives form a bevy of key opinion leaders in the field on hot topics and news from across the spectrum of cardiovascular medicine.
American College of Cardiology
MARCH 4, 2024
The goal of the STRONG-HF trial was to compare a high-intensity intervention involving up-titration of heart failure (HF) treatments versus usual care among participants with admission for acute HF.
HCPLive
MARCH 4, 2024
A secondary analysis of cross-sectional data found that serum albumin levels negatively correlated with the prevalence of diabetic retinopathy.
Journal of Cardiovascular Pharmacology
MARCH 4, 2024
Peripheral arterial disease (PAD) is the third leading cause of atherosclerotic morbidity after coronary heart disease and stroke yet is widely underdiagnosed and undertreated. Treatment of risk factors such as diabetes and cigarette smoking can benefit patients with PAD. Patients should have adequate blood pressure and lipid control to decrease clinical manifestations and symptoms of PAD.
HCPLive
MARCH 4, 2024
The primary endpoint was achieved, with biosimilar CT-P41 demonstrating comparable pharmacokinetics.
Journal of Cardiovascular Pharmacology
MARCH 4, 2024
Diastolic dysfunction (DD) in heart failure (HF) is associated with increased myocardial cytosolic calcium, and calcium-efflux via the sodium-calcium-exchanger depends on the sodium gradient. Beta-3-adrenoceptor (β3-AR) agonists lower cytosolic sodium and have reversed organ congestion. Accordingly, β3-AR agonists might improve diastolic function, which we aimed to assess.
Expert insights. Personalized for you.
134 
Let's personalize your content